Results 171 to 180 of about 7,465 (248)

Real-time detection of extravasation events of diagnostic and therapeutic radiopharmaceuticals in oncology. [PDF]

PLoS One
Cucurachi N, Fioroni F, Grassi E, Panico N, Verzellesi L, Botti A, Fraternali A, Roncali M, Durmo R, Filice A, Iori M.   +10 more
europepmc   +1 more source

Repurposing radiopharmaceutical carriers for targeted drug delivery and theranostics: A translational framework. [PDF]

Pharm Sci Adv
Shahiwala AF.
europepmc   +1 more source

Gold Nanorod-Radiopharmaceutical Conjugates for Nuclear Medicine Theranostics: A Methodological and Multiscale Perspective. [PDF]

Int J Mol Sci
Binelli L, Attili A, Venditti I, Battocchio C, Dini V, Calcagni ML, Ranaldi M, Iucci G, Tortora L, Grande S, Palma A, De Berardis B, Ammendolia MG, Scotognella T, Campanaro F, Dettin M, Bianchi L, Rosi A, Fabbri A.   +18 more
europepmc   +1 more source

The use of mass cytometry (CyTOF) to evaluate the cellular uptake of stable radiopharmaceutical surrogates in single cells: a proof-of-concept study. [PDF]

EJNMMI Radiopharm Chem
Gómez-Sánchez M, Blanco-González E, Montes-Bayón M, Behe M, Schibli R, Rioja-Blanco E.   +5 more
europepmc   +1 more source

Theranostics and molecular imaging are taking off: current situation, requirements and how to train more physicians to fill the gap. A perspective from three different continents. [PDF]

Br J Radiol
Veit-Haibach P, Lam W, Wong RKS, Cook GJR.   +3 more
europepmc   +1 more source

Challenges in radiopharmaceutical importation across six Southern African Development Community countries: an exploratory study. [PDF]

Front Med (Lausanne)
Mkhombo VG, Mosima L, Summers B.
europepmc   +1 more source

Using advanced cell models for targeted radionuclide therapy evaluation: increased efficacy in 3D versus 2D. [PDF]

EJNMMI Res
Klomp MJ, Erkens SE, van den Brink L, van Weerden WM, Dalm SU.   +4 more
europepmc   +1 more source

Prognostic Value of Cycle 1 SPECT SUV_mean in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ¹⁷⁷Lu-PSMA-617. [PDF]

J Nucl Med
Ghodsi A, Demirci RA, Gulati R, Nelson PS, Raychaudhuri R, Cheng HH, Sunkara R, Khan H, Rios RN, Hsieh A, Grivas P, Montgomery B, Yezefski TA, Yu EY, Schweizer MT, Chen DL, Iravani A.   +16 more
europepmc   +1 more source

Development and production of radiopharmaceuticals in National Institute of Radiological Sciences (NIRS)]

Development and production of radiopharmaceuticals in National Institute of Radiological Sciences (NIRS)]
Eighth China-Japan Joint Seminar on Radiopharmaceutical ...
openaire  

Targeted β^--Particle Plus Conversion and Auger-Electron Therapy with ¹⁶¹Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 Study. [PDF]

J Nucl Med
Fricke JG, Westerbergh F, McDougall L, Favaretto C, Christ E, Nicolas GP, Geistlich S, Schmid DE, Borgna F, Fani M, Bernhardt P, van der Meulen NP, Müller C, Schibli R, Wild D.   +14 more
europepmc   +1 more source